Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA To Unveil Drug Identifier System Soon, Short On Enforcement Authority

Executive Summary

FDA is preparing to release guidance on a system for uniquely identifying units of prescription drugs

You may also be interested in...



FDA Takes First Step Towards "Track And Trace" As Final Guidance Lengthens Identifiers For Drug Packaging

Agency had proposed an eight-digit system, but moved to 20 digits in final document after recommendation from PhRMA.

Globalization Bill Creates Fees For Generic Pre-approval Inspections

A system for assessing fees for generic drug applicants to pay for pre-approval inspections is included in the 1FDA Globalization Act introduced in the House Jan. 28

Drug Manufacturer Supply Options Could Be Constricted By Legislation

A more compact supply chain for pharmaceutical companies could result from congressional efforts to legislate greater emphasis on drug quality - both by FDA and by industry

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS052032

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel